Report Detail

Request for Sample of this report

Pharma & Healthcare Global Low-dose Birth Control Pill Market Growth 2022-2028

  • RnM4489219
    • |
  • 01 September, 2022
    • |
  • Global
    • |
  • 116 Pages
    • |
  • LPI(LP Information)
    • |
  • Pharma & Healthcare

The global market for Low-dose Birth Control Pill is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Low-dose Birth Control Pill market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Low-dose Birth Control Pill market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Low-dose Birth Control Pill market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Low-dose Birth Control Pill market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Low-dose Birth Control Pill players cover Lo Loestrin, Slynd, Balcoltra, Nextstellis and Taytulla, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Low-dose Birth Control Pill market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Low-dose Birth Control Pill market, with both quantitative and qualitative data, to help readers understand how the Low-dose Birth Control Pill market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

Market Segmentation:
The study segments the Low-dose Birth Control Pill market and forecasts the market size by Type (Ethinyl Estradiol, Drospirenone and Levonorgestrel), by Channel (Offline Sales and Online Sales.), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Ethinyl Estradiol
Drospirenone
Levonorgestrel
Norethindrone
Others

Segmentation by channel
Offline Sales
Online Sales

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Lo Loestrin
Slynd
Balcoltra
Nextstellis
Taytulla
Bayer
Phexxi
Viatris
Tyblume
Twirla
Xulane
Alloy
Pfizer
Organon
Janssen

Chapter Introduction
Chapter 1: Scope of Low-dose Birth Control Pill, Research Methodology, etc.
Chapter 2: Executive Summary, global Low-dose Birth Control Pill market size (sales and revenue) and CAGR, Low-dose Birth Control Pill market size by region, by type, by channel, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Low-dose Birth Control Pill sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Low-dose Birth Control Pill sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Low-dose Birth Control Pill market size forecast by region, by country, by type, and channel.
Chapter 13: Comprehensive company profiles of the leading players, including Lo Loestrin, Slynd, Balcoltra, Nextstellis, Taytulla, Bayer, Phexxi, Viatris and Tyblume, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Low-dose Birth Control Pill Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Low-dose Birth Control Pill by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Low-dose Birth Control Pill by Country/Region, 2017, 2022 & 2028
  • 2.2 Low-dose Birth Control Pill Segment by Type
    • 2.2.1 Ethinyl Estradiol
    • 2.2.2 Drospirenone
    • 2.2.3 Levonorgestrel
    • 2.2.4 Norethindrone
    • 2.2.5 Others
  • 2.3 Low-dose Birth Control Pill Sales by Type
    • 2.3.1 Global Low-dose Birth Control Pill Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Low-dose Birth Control Pill Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Low-dose Birth Control Pill Sale Price by Type (2017-2022)
  • 2.4 Low-dose Birth Control Pill Segment by Channel
    • 2.4.1 Offline Sales
    • 2.4.2 Online Sales
  • 2.5 Low-dose Birth Control Pill Sales by Channel
    • 2.5.1 Global Low-dose Birth Control Pill Sale Market Share by Channel (2017-2022)
    • 2.5.2 Global Low-dose Birth Control Pill Revenue and Market Share by Channel (2017-2022)
    • 2.5.3 Global Low-dose Birth Control Pill Sale Price by Channel (2017-2022)

3 Global Low-dose Birth Control Pill by Company

  • 3.1 Global Low-dose Birth Control Pill Breakdown Data by Company
    • 3.1.1 Global Low-dose Birth Control Pill Annual Sales by Company (2020-2022)
    • 3.1.2 Global Low-dose Birth Control Pill Sales Market Share by Company (2020-2022)
  • 3.2 Global Low-dose Birth Control Pill Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Low-dose Birth Control Pill Revenue by Company (2020-2022)
    • 3.2.2 Global Low-dose Birth Control Pill Revenue Market Share by Company (2020-2022)
  • 3.3 Global Low-dose Birth Control Pill Sale Price by Company
  • 3.4 Key Manufacturers Low-dose Birth Control Pill Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Low-dose Birth Control Pill Product Location Distribution
    • 3.4.2 Players Low-dose Birth Control Pill Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Low-dose Birth Control Pill by Geographic Region

  • 4.1 World Historic Low-dose Birth Control Pill Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Low-dose Birth Control Pill Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Low-dose Birth Control Pill Annual Revenue by Geographic Region
  • 4.2 World Historic Low-dose Birth Control Pill Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Low-dose Birth Control Pill Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Low-dose Birth Control Pill Annual Revenue by Country/Region
  • 4.3 Americas Low-dose Birth Control Pill Sales Growth
  • 4.4 APAC Low-dose Birth Control Pill Sales Growth
  • 4.5 Europe Low-dose Birth Control Pill Sales Growth
  • 4.6 Middle East & Africa Low-dose Birth Control Pill Sales Growth

5 Americas

  • 5.1 Americas Low-dose Birth Control Pill Sales by Country
    • 5.1.1 Americas Low-dose Birth Control Pill Sales by Country (2017-2022)
    • 5.1.2 Americas Low-dose Birth Control Pill Revenue by Country (2017-2022)
  • 5.2 Americas Low-dose Birth Control Pill Sales by Type
  • 5.3 Americas Low-dose Birth Control Pill Sales by Channel
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Low-dose Birth Control Pill Sales by Region
    • 6.1.1 APAC Low-dose Birth Control Pill Sales by Region (2017-2022)
    • 6.1.2 APAC Low-dose Birth Control Pill Revenue by Region (2017-2022)
  • 6.2 APAC Low-dose Birth Control Pill Sales by Type
  • 6.3 APAC Low-dose Birth Control Pill Sales by Channel
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Low-dose Birth Control Pill by Country
    • 7.1.1 Europe Low-dose Birth Control Pill Sales by Country (2017-2022)
    • 7.1.2 Europe Low-dose Birth Control Pill Revenue by Country (2017-2022)
  • 7.2 Europe Low-dose Birth Control Pill Sales by Type
  • 7.3 Europe Low-dose Birth Control Pill Sales by Channel
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Low-dose Birth Control Pill by Country
    • 8.1.1 Middle East & Africa Low-dose Birth Control Pill Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Low-dose Birth Control Pill Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Low-dose Birth Control Pill Sales by Type
  • 8.3 Middle East & Africa Low-dose Birth Control Pill Sales by Channel
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Low-dose Birth Control Pill
  • 10.3 Manufacturing Process Analysis of Low-dose Birth Control Pill
  • 10.4 Industry Chain Structure of Low-dose Birth Control Pill

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Low-dose Birth Control Pill Distributors
  • 11.3 Low-dose Birth Control Pill Customer

12 World Forecast Review for Low-dose Birth Control Pill by Geographic Region

  • 12.1 Global Low-dose Birth Control Pill Market Size Forecast by Region
    • 12.1.1 Global Low-dose Birth Control Pill Forecast by Region (2023-2028)
    • 12.1.2 Global Low-dose Birth Control Pill Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Low-dose Birth Control Pill Forecast by Type
  • 12.7 Global Low-dose Birth Control Pill Forecast by Channel

13 Key Players Analysis

  • 13.1 Lo Loestrin
    • 13.1.1 Lo Loestrin Company Information
    • 13.1.2 Lo Loestrin Low-dose Birth Control Pill Product Offered
    • 13.1.3 Lo Loestrin Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Lo Loestrin Main Business Overview
    • 13.1.5 Lo Loestrin Latest Developments
  • 13.2 Slynd
    • 13.2.1 Slynd Company Information
    • 13.2.2 Slynd Low-dose Birth Control Pill Product Offered
    • 13.2.3 Slynd Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Slynd Main Business Overview
    • 13.2.5 Slynd Latest Developments
  • 13.3 Balcoltra
    • 13.3.1 Balcoltra Company Information
    • 13.3.2 Balcoltra Low-dose Birth Control Pill Product Offered
    • 13.3.3 Balcoltra Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Balcoltra Main Business Overview
    • 13.3.5 Balcoltra Latest Developments
  • 13.4 Nextstellis
    • 13.4.1 Nextstellis Company Information
    • 13.4.2 Nextstellis Low-dose Birth Control Pill Product Offered
    • 13.4.3 Nextstellis Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Nextstellis Main Business Overview
    • 13.4.5 Nextstellis Latest Developments
  • 13.5 Taytulla
    • 13.5.1 Taytulla Company Information
    • 13.5.2 Taytulla Low-dose Birth Control Pill Product Offered
    • 13.5.3 Taytulla Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Taytulla Main Business Overview
    • 13.5.5 Taytulla Latest Developments
  • 13.6 Bayer
    • 13.6.1 Bayer Company Information
    • 13.6.2 Bayer Low-dose Birth Control Pill Product Offered
    • 13.6.3 Bayer Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Bayer Main Business Overview
    • 13.6.5 Bayer Latest Developments
  • 13.7 Phexxi
    • 13.7.1 Phexxi Company Information
    • 13.7.2 Phexxi Low-dose Birth Control Pill Product Offered
    • 13.7.3 Phexxi Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Phexxi Main Business Overview
    • 13.7.5 Phexxi Latest Developments
  • 13.8 Viatris
    • 13.8.1 Viatris Company Information
    • 13.8.2 Viatris Low-dose Birth Control Pill Product Offered
    • 13.8.3 Viatris Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 Viatris Main Business Overview
    • 13.8.5 Viatris Latest Developments
  • 13.9 Tyblume
    • 13.9.1 Tyblume Company Information
    • 13.9.2 Tyblume Low-dose Birth Control Pill Product Offered
    • 13.9.3 Tyblume Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 Tyblume Main Business Overview
    • 13.9.5 Tyblume Latest Developments
  • 13.10 Twirla
    • 13.10.1 Twirla Company Information
    • 13.10.2 Twirla Low-dose Birth Control Pill Product Offered
    • 13.10.3 Twirla Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 Twirla Main Business Overview
    • 13.10.5 Twirla Latest Developments
  • 13.11 Xulane
    • 13.11.1 Xulane Company Information
    • 13.11.2 Xulane Low-dose Birth Control Pill Product Offered
    • 13.11.3 Xulane Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.11.4 Xulane Main Business Overview
    • 13.11.5 Xulane Latest Developments
  • 13.12 Alloy
    • 13.12.1 Alloy Company Information
    • 13.12.2 Alloy Low-dose Birth Control Pill Product Offered
    • 13.12.3 Alloy Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.12.4 Alloy Main Business Overview
    • 13.12.5 Alloy Latest Developments
  • 13.13 Pfizer
    • 13.13.1 Pfizer Company Information
    • 13.13.2 Pfizer Low-dose Birth Control Pill Product Offered
    • 13.13.3 Pfizer Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.13.4 Pfizer Main Business Overview
    • 13.13.5 Pfizer Latest Developments
  • 13.14 Organon
    • 13.14.1 Organon Company Information
    • 13.14.2 Organon Low-dose Birth Control Pill Product Offered
    • 13.14.3 Organon Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.14.4 Organon Main Business Overview
    • 13.14.5 Organon Latest Developments
  • 13.15 Janssen
    • 13.15.1 Janssen Company Information
    • 13.15.2 Janssen Low-dose Birth Control Pill Product Offered
    • 13.15.3 Janssen Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.15.4 Janssen Main Business Overview
    • 13.15.5 Janssen Latest Developments

14 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Low-dose Birth Control Pill. Industry analysis & Market Report on Low-dose Birth Control Pill is a syndicated market report, published as Global Low-dose Birth Control Pill Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Low-dose Birth Control Pill market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,840.16
5,680.32
3,411.12
6,822.24
564,701.40
1,129,402.80
308,611.20
617,222.40
Credit card Logo
Sample Question Discount Download PDF

Related Reports

Reason to Buy

  • Trusted By Leaders

    Top executives from leading companies purchase research reports from us. 

  • Shop With Confidence

    We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

  • Customer Centric

    Need assistance related to your research requirements? We are just a phone call or an email away.

  • Personalized Solutions

    Our experienced research specialists are here to help you locate the right reports for your need.

  • Secure Checkout

    Shop without being worried about safety & security of your transactions.
    •

Request for Sample of this report

Reports and Markets

mcafree

Contact Us

+1-352-353-0818 (US)

info@reportsandmarkets.com

Support

EMAIL US

Newsletter

KEEP UP TO DATE ON ALL THE LATEST REPORTS


maxmind_logo